References
- McIntosh K. Community-acquired pneumonia in children. N Engl J Med. 2002;346(6):429–437.
- Barrett C, Ben-Shimol S, Greenberg D. Differences between radiologically confirmed pneumonia with and without pleural fluid in hospitalized children younger than 5 years in Southern Israel. Clin Pediatr (Phila). 2016;55(10):897–903.
- Fletcher MA, Schmitt HJ, Syrochkina M, et al. Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. Eur J Clin Microbiol Infect Dis. 2014;33(6):879–910.
- Tan TQ, Mason EO Jr, Wald ER, et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002;110(1):1–6.
- Goldbart AD, Leibovitz E, Porat N, et al. Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine. Scand J Infect Dis. 2009;41(3):182–187.
- Lin CJ, Chen PY, Huang FL, et al. Radiographic, clinical, and prognostic features of complicated and uncomplicated community-acquired lobar pneumonia in children. J Microbiol Immunol Infect. 2006;39(6):489–495.
- Chibuk TK, Robinson JL, Hartfield DS. Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7). Eur J Pediatr. 2010;169(9):1123–1128.
- Fuchs I, Dagan R, Givon-Lavi N, et al. Serotype 1 childhood invasive pneumococcal disease has unique characteristics compared to disease caused by other Streptococcus pneumoniae serotypes. Pediatr Infect Dis J. 2013;32(6):614–618.
- Grijalva CG, Nuorti JP, Zhu Y, et al. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis. 2010;50(6):805–813.
- Strachan RE, Snelling TL, Jaffe A. Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine. Bull World Health Organ. 2013;91(3):167–173.
- Saxena S, Atchison C, Cecil E, et al. Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England. J Infect. 2015;71(4):428–436.
- Picazo J, Ruiz-Contreras J, Casado-Flores J, et al. Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain. Clin Vaccine Immunol. 2013;20(10):1524–1530.
- Greenberg D, Givon-Lavi N, Ben-Shimol S, et al. Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years. Vaccine. 2015;33(36):4623–4629.
- Ben-Shimol S, Greenberg D, Givon-Lavi N, et al. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance. Vaccine. 2014;32(27):3452–3459.
- Statistical Abstracts of Israel, 2016. No. 67. Jerusalem, State of Israel: Central Bureau of Statistics; 2016.
- Ben-Shimol S, Givon-Lavi N, Greenberg D, et al. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel. Hum Vaccin Immunother. 2016;12(2):268–276.
- Cherian T, Mulholland EK, Carlin JB, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005;83(5):353–359.
- Greenberg D, Givon-Lavi N, Faingelernt Y, et al. Nasopharyngeal pneumococcal carriage during childhood community-acquired alveolar pneumonia: Relationship between specific serotypes and coinfecting viruses. J Infect Dis. 2017;215(7):1111–1116.
- Syrogiannopoulos GA, Michoula AN, Tsimitselis G, et al. Pneumonia with empyema among children in the first five years of high coverage with 13-valent pneumococcal conjugate vaccine. Infect Dis (Lond). 2016;48(10):749–753.
- Ben-Shimol S, Dagan R, Givon-Lavi N, et al. [Community acquired pneumonia (CAP) in children younger than 5 years of age in southern Israel]. Harefuah. 2010;149:137–142, 196.